Gevo, Inc.

Gevo, Inc. (GEVO) Market Cap

Gevo, Inc. has a market capitalization of .

No quote data available.

CEO: Paul D. Bloom

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 2011-02-09

Website: https://gevo.com

Gevo, Inc. (GEVO) - Company Information

Market Cap: -|Sector: Basic Materials

Company Profile

Gevo, Inc. is a company focused on the development and commercialization of renewable fuels. Its operations are organized into four distinct segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company's primary objective is to offer sustainable alternatives for gasoline, jet fuel, and diesel, striving to achieve zero carbon emissions and substantially lower overall greenhouse gas footprints. Their diverse product offerings include renewable versions of gasoline and diesel, sustainable aviation fuel (SAF), and renewable natural gas. Additionally, they produce specialty chemicals like isooctane, isobutanol, isobutylene, and ethanol, along with animal feed and protein. Gevo, Inc. has formed a strategic partnership with Axens North America, Inc. to advance ethanol-to-jet technology and further the commercial development of sustainable aviation fuel projects. Originally founded in 2005 as Methanotech, Inc., the company changed its name to Gevo, Inc. in March 2006. Its corporate headquarters are located in Englewood, Colorado.

Analyst Sentiment

67%
Buy

From 4 Active Polls

1Y Forecast: $2.88

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$2

Median

$3

High Bound

$4

Average

$3

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$2.88
▲ +94.59% Upside
Low Target
$2.00
35% Risk
Median Target
$2.88
94% Mid
High Target
$3.75
153% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 GEVO INC (GEVO) — Investment Overview

🧩 Business Model Overview

GEVO is a renewable fuels and advanced biofuels developer focused on producing lower–carbon-intensity alcohols (notably isobutanol) and upgrading them into transportation fuels, including sustainable aviation fuel (SAF)-type molecules. The economic model relies on converting agricultural feedstocks into fuels through a proprietary pathway and then monetizing both the fuel itself and the policy-driven value of reduced lifecycle carbon intensity (e.g., low-carbon fuel credits under schemes such as LCFS).

The value chain has two key components: (1) technology and process development (to improve yields, reduce operating costs, and enable economically attractive production), and (2) commercialization via plants and partnerships/offtakes that translate produced volumes into cash flows. Because biofuels and related molecules are typically purchased under contractual frameworks, customer demand is often supported by blending requirements and compliance-driven credit economics rather than purely spot-market pricing.

💰 Revenue Streams & Monetisation Model

  • Product sales (transactional, volume-driven): Revenue from selling produced renewable alcohols and/or downstream fuels/molecules into offtake arrangements.
  • Policy credit monetisation: Additional value tied to achieving lower lifecycle carbon intensity, which can generate credit revenue (or improve netback versus conventional fuels).
  • Technology monetisation (potential/variable): Licensing and/or process value sharing with partners, where commercialization structure allows technology to be monetized without full balance-sheet ownership of all production capacity.

Margin drivers tend to center on the netback after feedstock and operating costs, the carbon intensity performance (which influences credit availability and level), and utilization once capacity is commissioned. In this industry, profitability is often less about one-time technology breakthroughs and more about reaching a sustainable cost curve at scale while protecting credit economics.

🧠 Competitive Advantages & Market Positioning

GEVO’s competitive position is primarily rooted in cost advantages from process performance and monetisation of carbon-intensity reductions, supported by intangible assets in the form of proprietary pathways and know-how. The company’s structural edge is not a network effect; rather, it is the ability to achieve lower delivered costs and/or stronger credit economics than alternative pathways.

  • Low-cost feedstock and logistical linkage (geographic cost advantage): GEVO targets production in markets integrated with North American agricultural supply chains, where corn-derived inputs and established ethanol distribution infrastructure can reduce friction versus frontier locations.
  • Cost of production pathway (cost advantage): Proprietary process design aims to improve yield and reduce the variable cost burden per unit of fuel produced, which is critical because biofuels economics are highly sensitive to feedstock-to-fuel conversion efficiency.
  • Intangible assets: Process IP and engineering learnings that can lower future capital and operating requirements when expanding capacity or retrofitting.
  • Contracting/offtake alignment (quasi-switching benefit): Offtake agreements for lower-carbon fuels and the credit-linked economics create some customer dependency, though the durability depends on contract terms and ongoing policy support.

Competitive benchmarking:

  • POET (ethanol and renewable fuels): POET is more broadly scaled in conventional renewable ethanol with pathways that can benefit from established agribusiness integration. GEVO’s focus is narrower—centered on lower-carbon alcohol molecules and molecules aligned to SAF/carbon-reduction markets.
  • Butamax (isobutanol technology): Butamax competes on isobutanol pathway know-how and commercialization. GEVO differentiates by pursuing its specific process approach and by targeting carbon-intensity monetisation and downstream molecule demand.
  • LanzaTech (alternative SAF pathways): LanzaTech targets carbon-based feedstocks and gas fermentation routes. GEVO’s differentiation is more directly tied to agricultural supply chains and the performance of its specific low-carbon alcohol-to-fuel value chain.

Across these rivals, the market is segmented by pathway, feedstock economics, and the ability to secure durable credit/offtake structures. GEVO’s positioning is best understood as a pathway and cost-curve bet combined with carbon-credit monetisation.

🚀 Multi-Year Growth Drivers

  • SAF and low-carbon fuel policy expansion: Multi-year blending mandates and incentive frameworks continue to expand the demand for molecules that can meet lifecycle carbon targets.
  • Market widening for lower-carbon molecules: Use cases for isobutanol-derived products and SAF-compatible molecules support longer-duration offtake demand as compliance requirements mature.
  • Learning curve and scaling economics: Commissioning additional capacity can reduce unit costs through improved process efficiency, higher utilization, and supply-chain optimization.
  • Capacity re-purposing opportunities: The broader ethanol industry’s logistical and operational footprint can be leveraged for retrofits or integrations, improving the probability of achieving a bankable cost structure.

Over a 5–10 year horizon, the addressable market growth is driven less by discretionary fuel switching and more by compliance-driven demand for lower lifecycle carbon intensity. This makes credit and policy durability—combined with execution on cost—central to the long-term thesis.

⚠ Risk Factors to Monitor

  • Capital intensity and execution risk: Building or upgrading production assets requires sustained execution and financing access; delays or cost overruns can permanently impair project-level economics.
  • Policy and credit risk: Credit pricing, eligibility, and regulatory frameworks (e.g., LCFS-style mechanisms) can change, altering the netback versus conventional fuels.
  • Feedstock spread volatility: Biofuels profitability depends on the relationship between agricultural inputs, ethanol and renewable fuel pricing, and conversion efficiency.
  • Technological and scale-up risk: Laboratory or pilot performance may not fully translate to commercial reliability, yield, and uptime.
  • Competitive pressure across pathways: Rival pathways can compress economics if multiple technologies reach scale with similar or better lifecycle outcomes.
  • Offtake and counterparty risk: Project economics are sensitive to contract structure (pricing, volume commitments, and credit/quality specifications).

📊 Valuation & Market View

Market valuation for advanced biofuels developers typically reflects optionality on commercialization rather than mature cash-flow multiples. Investors often look to metrics such as:

  • Enterprise value versus forward capital deployment or project-level economics
  • Implied cost curve and probability-weighted project milestones
  • Sensitivity to credit pricing and feedstock spreads
  • Credible offtake coverage and commissioning timelines

Key drivers moving the valuation needle include: (1) demonstration of an economically competitive unit cost at scale, (2) durability of low-carbon credit economics, and (3) progress in securing contracts that convert production capacity into bankable revenue streams.

🔍 Investment Takeaway

GEVO’s long-term investment case rests on achieving a sustainable cost and carbon-intensity advantage through proprietary process technology, integrated production execution, and monetization of low-carbon fuel value under policy frameworks. The moat is best characterized as a cost curve plus carbon-credit monetisation advantage supported by intangible process assets and commercialization experience—not a network effect. The principal underwriting question is whether GEVO can translate pathway performance into repeatable commercial-scale economics while navigating capital intensity and policy sensitivity.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"GEVO reported Q1’26 (ended 2026-03-31) revenue of $42.95M and net income of $0.35M (EPS: -$0.09). Revenue rose slightly QoQ (+% vs 2025-12-31’s $45.35M shows a decline) and improved vs Q1’25 ($29.11M), representing +47.6% YoY. Profitability improved on an operating basis versus the immediately prior quarter: operating income was -$4.90M in Q1’26 compared with -$5.36M in Q4’25, while the net margin turned positive at +0.8% versus -13.2% in Q4’25. Over the broader 4-quarter strip, results have been highly volatile—Q2’25 showed strong profitability (net margin +4.9%), followed by net losses in Q3’25 (-18.6% margin) and Q4’25 (-13.2%), with Q1’26 returning to a small profit. Cash flow remains the key swing factor. Operating cash flow was -$21.1M in Q1’26 and free cash flow -$21.1M, reflecting weaker cash conversion after positive OCF in Q4’25 (+$20.0M). Balance sheet liquidity looks materially stronger in Q1’26 with cash & equivalents of $78.9M and a return to net cash (net debt -$75.4M), versus net debt +$166.4M in Q4’25. Shareholder returns appear strong on price momentum: the stock is up ~45.3% over 1 year, with a 0% dividend and no disclosed buyback support in the provided cash flow (only a modest repurchase of $0.47M)."

Revenue Growth

Neutral

Revenue was $42.95M in Q1’26 vs $29.11M in Q1’25 (+47.6% YoY). QoQ, revenue declined vs $45.35M in Q4’25 (about -5.3%), indicating improving but not consistently strengthening momentum.

Profitability

Fair

Net income in Q1’26 was $0.35M versus -$6.01M in Q4’25 (margin flipped to +0.8%). However, profitability remains unstable across the 4-quarter window (net margin +4.9% in Q2’25, -18.6% in Q3’25, -13.2% in Q4’25). Operating income was still negative (-$4.90M).

Cash Flow Quality

Neutral

Cash generation weakened in Q1’26: operating cash flow was -$21.1M and free cash flow -$21.1M, following positive Q4’25 OCF (+$20.0M) and despite near-term profitability improving. No dividends; buybacks were limited (repurchase of ~$0.47M).

Leverage & Balance Sheet

Positive

Liquidity improved sharply in Q1’26 with cash & equivalents of $78.9M and net debt turning into net cash (-$75.4M), compared with net debt of +$166.4M in Q4’25. Equity also remains sizable ($447.7M), supporting resilience for a highly volatile earnings profile.

Shareholder Returns

Good

Total return is supported mainly by capital appreciation: 1-year price change is +45.3% (>20% threshold). Dividend yield is 0%; buyback effect appears small in the provided quarter.

Analyst Sentiment & Valuation

Fair

Consensus price target is $3.50 with the stock price around $1.70, implying meaningful upside on paper. However, valuation multiples are difficult to interpret amid losses/volatility (e.g., trailing P/E not meaningful; cash flow metrics negative).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So what: GEVO exited Q1 2026 with momentum in its operating base (positive adjusted EBITDA of $9M vs a prior-year loss), driven by improved margins and strong production volumes across carbon capture, low-carbon ethanol, and RNG. Management reiterated a $40M annualized adjusted EBITDA run-rate target by end of 2026 from existing operations, while positioning debottlenecking (+10% to 15% segment EBITDA) and a major capacity expansion (+75M gallons/year to 150M total) as incremental. The key execution hinge is financing and offtake for ATJ 30 (Project North Star). DOE financing was exited due to revised loan guarantee conditions; however, management claims multiple lender interest and intends to reach FID by end of 2026. Analysts drilled into timing (2027 financial impact from debottlenecking), balance-sheet exposure (Ara Energy + project debt), and the remaining offtake “bankable contract” gap (term-sheet stage; targeting 70%–80% contracted coverage).

AI IconGrowth Catalysts

  • Gevo, North Dakota debottlenecking expected to expand adjusted EBITDA in the segment by 10% to 15%, with operational reliability projects targeted for completion by end of 2026 (financial impact expected starting 2027).
  • Capacity expansion at Gevo, North Dakota from 75 million to 150 million gallons/year (up to +75 million gallons/year), doubling carbon capture and low-carbon ethanol output; construction timeline 18 to 24 months after final investment decision.
  • Project North Star (ATJ 30) FEL milestones: Stage 2 completed; FEL3 expected to be completed this quarter to tighten capital cost and enable detailed engineering.
  • Verity franchise growth: signed up 8 customers; catalyst depends on 45Z ag benefits being included for expanded adoption.

Business Development

  • Ara Energy (preliminary co-invest/co-financing agreement) for Gevo, North Dakota expansion capitalization.
  • Fluid Quip Technologies mentioned as an existing partner supporting expansion engineering/construction approach.
  • Project North Star financing/offtake: secured ~half of financeable long-term contracts for synthetic aviation fuel and carbon attributes; additional term-sheet-stage contracts expected to complete financing requirements.
  • Carbon/credit customers and transactions: CDR purchases/retirements by Amgen, Bank of Montreal, and PayPal; additional longer-term CDR deal advancement mentioned.
  • Verity partnerships/customers: Bushel (services ~50% of grain elevators in the U.S. and Canada) and Cboe (data acquisition/field execution); Verity signed up 8 customers so far.

AI IconFinancial Highlights

  • Revenue $43M in Q1 2026 vs $29M in Q1 2025.
  • Net loss attributable to Gevo: $22M or ($0.09) per share, same as prior-year quarter.
  • Non-GAAP adjusted EBITDA: $9M in Q1 2026 vs adjusted EBITDA loss of $15M in Q1 2025; quarter included $11M debt extinguishment/modification.
  • Carbon monetization: sold ~57% of carbon attributes attached to fuel in Q1; generated nearly 20,000 tons of engineered CDRs sold into voluntary market.
  • Full-year adjusted EBITDA guidance: expects ~$30M of adjusted EBITDA over 12 months 2026 (implies annualized run rate) and reaffirms target to reach $40M annualized run-rate adjusted EBITDA by end of 2026 from existing operations (expansion/debottlenecking considered incremental).
  • Operating cash flow: negative $21M; attributed to timing effects—$17M tax credits generated but not yet monetized and ~$4M one-time costs tied to debt refinancing/extinguishment.

AI IconCapital Funding

  • Cash & equivalents: ~$79M at quarter-end.
  • No buyback disclosed.
  • ATJ 30 (Project North Star) financing: pursuing non-dilutive project-level debt plus strategic capital; received nonbinding indications of interest from multiple lenders; target FID by end of 2026.
  • ATJ 30 leverage target: ~60% of total project cost covered via project financing.
  • Gevo, North Dakota expansion financing: combination of Ara Energy capital plus project-level debt; management indicates no additional burden on Gevo balance sheet beyond capital/capital-stack planning.
  • Debottlenecking/site improvements capex: $26M expected for 2026, funded internally from Gevo, North Dakota operating cash flows.

AI IconStrategy & Ops

  • Launched corporate-wide “EBITDA challenge” with employee incentive plan and metric capture; framed as revenue growth + operational performance + cost management rather than pure cost cutting.
  • Debottlenecking operational readiness: April planned shutdown completed process tie-ins; management believes no additional/unplanned outages needed to complete and commission debottlenecking.
  • New equipment under construction (Gevo, North Dakota): new fermenter, liquefaction tank, beer degafting system, and new milling building; capacity target ~75M gallons/year starting 2027 vs current nameplate 67M (already exceeding).
  • ATJ 30 capex estimate refinement: completion of FEL3 to improve capital cost estimates; modularization work by Praj and integration via U.S. engineering partners in India-linked efforts noted.

AI IconMarket Outlook

  • Project North Star financing timeline: secure financing by end of 2026; FID targeted after securing additional term-sheet-stage contracts.
  • Debottlenecking EBITDA contribution timing: extra volumes and financial impact expected to begin in 2027 (Q1 start referenced).
  • Carbon/low-carbon ethanol demand: management expects continued growth in 2026 even before Vivo, North Dakota debottlenecking enters.

AI IconRisks & Headwinds

  • Project North Star DOE withdrawal: management withdrew from DOE financing process due to new loan guarantee requirements (enhanced oil recovery as a business objective) misaligned with value-maximization and timeline.
  • ATJ 30 gating item: additional bankable offtake contracts remain at term-sheet stage; management cited offtakes as the major remaining gating item for financing.
  • Seasonality/commodity dynamics: management referenced typical quarter-to-quarter variability in adjusted EBITDA tied to ethanol margin seasonality (Q1 considered improved despite seasonal softness).
  • Policy/catalyst risk for Verity: need confirmation/approval that 45Z ag benefits are included; awaiting this inclusion was described as necessary catalyst for broader uptake.

Q&A: Analyst Interest

  • Debottlenecking impact timing and financial recognition: Management confirmed the debottlenecking volume unlocks should flow through financials starting in 2027, referencing that tie-ins for expansion were already executed and work will finish by end of 2026, enabling 10% to 15% incremental adjusted EBITDA from early 2027.
  • Ara Energy expansion funding mechanics and balance-sheet burden: Management indicated expansion capital will be completed via a project-level debt arrangement plus Ara Energy capital; cash on hand plus Ara capital completes the required stack. Management emphasized project financing to avoid burdening Gevo’s balance sheet and reduce dilution risk.
  • ATJ 30 financing gating items, contract coverage, and economics mix: Management said offtakes are the major gating item still in term-sheet stage, and they want sufficient contracted offtakes (typically 70%–80% range) to satisfy capital providers while maintaining free-to-sell volume for opportunistic upside based on carbon values and jet prices.

Sentiment: MIXED

Note: This summary was synthesized by AI from the GEVO Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Gevo, Inc. (GEVO) Financial Profile